Prostate Active Surveillance Study


I'm Interested

Trial ID: NCT00756665


The Prostate Active Surveillance Study (PASS) is a research study for men who have chosen active surveillance as a management plan for their prostate cancer. Active surveillance is defined as close monitoring of prostate cancer with the offer of treatment if there are changes in test results. This study seeks to discover markers that will identify cancers that are more aggressive from those tumors that grow slowly.

Official Title

Canary Prostate Active Surveillance Study

Stanford Investigator(s)

James D. Brooks
James D. Brooks

Keith and Jan Hurlbut Professor

Harcharan Gill
Harcharan Gill

Kathryn Simmons Stamey Professor, Emeritus

Benjamin I. Chung
Benjamin I. Chung

Associate Professor of Urology


Inclusion Criteria:

   - Histologically confirmed adenocarcinoma of the prostate.

   - Clinically localized prostate cancer: T1-2, NX or N0, MX or M0.

   - No previous treatment for prostate cancer (including hormonal therapy, radiation
   therapy, surgery, or chemotherapy).

   - ECOG Performance Status 0 or 1.

   - Patient has elected Active Surveillance as preferred management plan for prostate

   - Patient consent has been obtained according to local Institutional Review Board for
   acquisition of research specimens.

   - Patient is accessible and compliant for follow-up.

   - Prostate biopsy requirements:

      1. If diagnosis was within one year of baseline visit, participant must have at
      least one biopsy with at least 10 cores.

      2. If diagnosis was more than 1 year prior to baseline visit, participant must have
      a minimum of 2 biopsies, one of which must be within 2 years prior to baseline

Exclusion Criteria:

   - Unwillingness or inability to undergo serial prostate biopsy.

   - History of other malignancies, except: adequately treated non-melanoma skin cancer or
   adequately treated superficial bladder cancer (Ta) or other solid tumors curatively
   treated with no evidence of disease for > 5 years.


I'm Interested

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Michelle Ferrari

New Trial Alerts

Receive email alerts when trials open to patients.